ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.90
-1.00%
Dow Jones
37,958.01
-1.12%
US Dollar vs MXN
17.11379
0.59%
Brent Oil
86.135
-1.32%
Bitcoin
60,378.65
-5.41%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Marinus Pharmaceuticals Inc (MRNS)

  7. Marinus Pharmaceuticals Inc (MRNS) Noticias

MRNS Marinus Pharmaceuticals Inc

1.425
0.025 (1.79%)
Última actualización: 13:45:29
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Marinus Pharmaceuticals Inc MRNS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.025 1.79% 1.425 13:45:29
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.42 1.39 1.43 1.40
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
15/4/202406:00BWMarinus Pharmaceuticals Provides Update on the Phase 3 RAISE..
05/4/202415:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
27/3/202407:41BWMarinus Pharmaceuticals Comments on Patent Challenge by Ovid..
05/3/202415:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202415:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
22/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202406:00BWMarinus Pharmaceuticals to Present at Upcoming Investor..
20/2/202406:00BWMarinus Pharmaceuticals to Provide Business Update and..
16/2/202415:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
14/2/202415:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202411:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202409:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202408:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202411:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
04/1/202406:04EDGAR2Form 8-K - Current report
04/1/202406:01BWMarinus Pharmaceuticals Reports Preliminary Fourth Quarter..
07/12/202315:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
28/11/202306:05EDGAR2Form 8-K - Current report
20/11/202315:01BWMarinus Pharmaceuticals Announces Seven Presentations at AES..
14/11/202315:05BWMarinus Pharmaceuticals to Present at the 6th Annual..
09/11/202315:30BWMarinus Pharmaceuticals Announces Inducement Grants Under..
07/11/202306:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:11EDGAR2Form 8-K - Current report
07/11/202306:01BWMarinus Pharmaceuticals Provides Business Update and Reports..
07/11/202306:00BWMarinus Pharmaceuticals Initiates Global Access Program for..
24/10/202306:01BWMarinus Pharmaceuticals to Provide Business Update and..
10/10/202315:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/10/202315:00BWMarinus Pharmaceuticals Announces Inducement Grants Under..
28/9/202306:05EDGAR2Form 8-K - Current report
21/9/202315:00BWMarinus Pharmaceuticals to Present at the 2023 Cantor Global..
19/9/202307:02EDGAR2Form 8-K - Current report
19/9/202307:00BWMarinus Pharmaceuticals Highlights Advancing Pipeline and..
12/9/202315:00BWMarinus Pharmaceuticals Announces Speakers for Hybrid..
06/9/202315:01BWMarinus Pharmaceuticals Announces Inducement Grants Under..

Su Consulta Reciente

NASDAQ
MRNS
Marinus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados